Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6465764

CON(C)C(=O)CCCc1ccccc1.O=C(O)C(F)(F)F

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 8/20 0.52
FAAH O00519 3/20 0.49
CES1 P23141 3/20 0.49
HDAC3 O15379 2/20 0.46
HDAC4 P56524 2/20 0.46
HDAC1 Q13547 2/20 0.46
HDAC7 Q8WUI4 2/20 0.46
HDAC2 Q92769 2/20 0.46
HDAC10 Q969S8 2/20 0.46
HDAC11 Q96DB2 2/20 0.46
HDAC8 Q9BY41 2/20 0.46
HDAC6 Q9UBN7 2/20 0.46
HDAC9 Q9UKV0 2/20 0.46
HDAC5 Q9UQL6 2/20 0.46
MAPK1 P28482 1/20 0.46
ADRA1A P35348 1/20 0.46
SLC6A3 Q01959 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
MLYCD O95822 3/20 0.45
KMT2A Q03164 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL829335 0.91 ALOX5 (0.61) ALOX5HDAC3HDAC4HDAC1HDAC7
SCHEMBL1667586 0.87 ALOX5 (0.69) ALOX5FAAHCES1HDAC3HDAC4
SCHEMBL1727025 0.82 KMT2A (0.62) ALOX5HDAC2HDAC8HDAC6MLYCD
SCHEMBL30765759 0.81 ALOX5 (0.57) ALOX5SMN1; SMN2
SCHEMBL13792415 0.77 ALOX5 (0.77) ALOX5KMT2A
SCHEMBL5321740 0.77 ALOX5 (0.55) ALOX5HDAC3HDAC4HDAC1HDAC7
SCHEMBL9835455 0.76 ALOX5 (0.61) ALOX5HDAC3HDAC4HDAC1HDAC7
Trifluoroacetic Acid SCHEMBL30882532 0.76 CES1 (0.60) ALOX5FAAHCES1HDAC3HDAC4
Trifluoroacetic Acid SCHEMBL30483155 0.76 CES1 (0.60) ALOX5FAAHCES1HDAC3HDAC4
SCHEMBL8358797 0.76 CYP2D6 (0.58)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1516877-A1 Amine derivatives as protease inhibitors AXYS PHARMACEUTICALS, INC. (US) 2005-03-23 EP disclosed